Brief: Genscript Biotech Announces Cooperation On Biologic License Application Of mRna Vaccines

Genscript Biotech

22/10/2021 09:40

Oct 22 (Reuters) - Genscript Biotech Corp  1548.HK :
    * GENSCRIPT BIOTECH ANNOUNCES COOPERATION ON BIOLOGIC
LICENSE
APPLICATION OF MRNA VACCINES AND ITS COMMERCIAL PRODUCTION
    * UNIT ENTERS MASTER SERVICE AGREEMENT WITH SUZHOU ABOGEN
BIOSCIENCE AND YUXI WALVAX BIOTECHNOLOGY FOR DEAL
    * WALVAX TO BE APPLICANT FOR PROJECT, UNIT TO BE EXCLUSIVE
SERVICES SUPPLIER FOR COMMERCIAL PRODUCTION OF PLASMID
    * AS OF DATE, PHASE III CLINICAL TRIALS OF PROJECT APPROVED
BY
DRUG ADMINISTRATION AUTHORITIES OF MEXICO, INDONESIA & NEPAL


Further company coverage:  1548.HK 

 (Reuters.Briefs@thomsonreuters.com)